Vasoactive Intestinal Peptide in COPD
NCT00464932
·
clinicaltrials.gov ↗
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
COPD
Pulmonary Hypertension
Interventions
DRUG:
Vasoactive Intestinal Peptide (VIP)
Sponsor
Medical University of Vienna